Legionnaires’ disease in Europe, 2010
This surveillance report is based on Legionnaires’ disease surveillance data collected for 2010. The surveillance is carried out by the European Disease Surveillance Network (ELDSNet) and coordinated by ECDC. The data are from all cases reported from EU Member States, Iceland and Norway; and from all travel-associated cases of Legionnaires disease (TALD).
In 2010, a total of 6 296 cases were notified by EU Member States, Iceland and Norway, yielding an overall notification number of 12.4 per million in inhabitants.
In 2010, a total of 6 296 cases of Legionnaires’ disease were notified by EU Member States, Iceland and Norway, with a 11% increase from 2009. The majority of the cases were community-acquired, while around 20% were travel-associated.
The surveillance activity was carried out by the European Legionnaires’ Disease Surveillance Network (ELDSNet) and coordinated by ECDC. This is the second annual report presenting the analysis of Legionnaires’ disease (LD) surveillance data in Europe. Data were collected through two different schemes, the first scheme covering all cases of LD reported from ELDSNet members, while the second scheme covers all reported cases of travel-associated Legionnaires’ disease (TALD), including reports from countries outside the EU. This document is therefore the first annual report that includes all reported cases of LD and TALD.
Collecting data on TALD at EU-level is crucial to identify and tackle clusters of Legionnaires’ disease that may not have been identified at a national level, particularly because in Europe, notification rates and laboratory diagnostic practice highly differ among countries.
Legionnaires’ disease is a multisystem disease involving pneumonia. Humans are infected by inhalation of aerosols containing Legionella bacteria. The diagnosis relies on specific laboratory tests, and the disease is considered to be widely underreported, mainly because it is under diagnosed by clinicians and under-notified to national authorities. The ELDSNet should continue its efforts on improving notification in countries where under-ascertainment probably remains quite high, especially by raising awareness, providing laboratory support and training, and evaluating the surveillance systems in place.
Smallpox - Annual Epidemiological Report for 2018
13 Nov 2019 - Smallpox was declared eradicated in 1980. There were no reports of confirmed or possible smallpox in the EU/EEA or other countries for 2018.
Tularaemia Annual Epidemiological Report for 2018
12 Nov 2019 - For 2018, 18 countries in the EU/EEA reported 441 cases of tularaemia, 358 (81%) of which were confirmed. The EU/EEA notification rate for 2018 was 0.07 cases per 100 000 population. The male-to-female ratio was 1.7:1. As in previous years, the notification rate among males was higher in most age groups except for the age groups between 5 and 24 years. Notification rates increased with age and peaked at 45–64 years.
Influenza virus characterisation, October 2019
11 Nov 2019 - This is the first report for the 2019–20 influenza season. As of week 44/2019, 1 138 influenza detections across the WHO European Region had been reported; 80% type A viruses, with A(H3N2) prevailing over A(H1N1)pdm09, and 20% type B viruses, with 26 of 27 (96%) ascribed to a lineage being B/Victoria.